4.7 Article

HMGA1-Regulating microRNAs Let-7a and miR-26a are Downregulated in Human Seminomas

Journal

Publisher

MDPI
DOI: 10.3390/ijms21083014

Keywords

HMGA1; microRNAs; TGCTs; seminomas

Funding

  1. PNR-CNR Aging Program 2012-2014
  2. CNR Flagship Projects (Epigenomics-EPIGEN)
  3. Associazione Italiana per la Ricerca sul Cancro [AIRC IG 11477]
  4. Programma Valere Plus, University of Campania L. Vanvitelli, Caserta, Italy

Ask authors/readers for more resources

Background: Recent studies have underlined HMGA protein's key role in the onset of testicular germ cell tumors, where HMGA1 is differently expressed with respect to the state of differentiation, suggesting its fine regulation as master regulator in testicular tumorigenesis. Several studies have highlighted that the HMGA1 transcript is strictly regulated by a set of inhibitory microRNAs. Thus, the aim of this study is to test whether HMGA1 overexpression in human seminomas may be induced by the deregulation of miR-26a and Let-7a-two HMGA1-targeting microRNAs. Methods: HMGA1 mRNA and Let-7a and miR-26a levels were measured in a seminoma dataset available in the Cancer Genome Atlas database and confirmed in a subset of seminomas by qRT-PCR and western blot. A TCam-2 seminoma cell line was then transfected with Let-7a and miR-26a and tested for proliferation and motility abilities. Results: an inverse correlation was found between the expression of miR-26a and Let-7a and HMGA1 expression levels in seminomas samples, suggesting a critical role of these microRNAs in HMGA1 levels regulation. Accordingly, functional studies showed that miR-26a and Let-7a inhibited the proliferation, migration and invasion capabilities of the human seminoma derived cell line TCam-2. Conclusions: these data strongly support that the upregulation of HMGA1 levels occurring in seminoma is-at least in part-due to the downregulation of HMGA1-targeting microRNAs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

The Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity

Simona Pellecchia, Romina Sepe, Myriam Decaussin-Petrucci, Cristina Ivan, Masayoshi Shimizu, Carmela Coppola, Domenico Testa, George Adrian Calin, Alfredo Fusco, Pierlorenzo Pallante

CANCERS (2020)

Review Oncology

Further insights into testicular germ cell tumor oncogenesis: potential therapeutic targets

Paolo Chieffi, Marco De Martino, Francesco Esposito

EXPERT REVIEW OF ANTICANCER THERAPY (2020)

Article Multidisciplinary Sciences

HMGA1-pseudogene7 transgenic mice develop B cell lymphomas

Marco De Martino, Davide De Biase, Floriana Forzati, Sara Carmela Credendino, Giuseppe Palma, Antonio Barbieri, Claudio Arra, Orlando Paciello, Eugenio Gaudio, Maurilio Ponzoni, Gabriella De Vita, Paolo Chieffi, Francesco Bertoni, Alfredo Fusco, Francesco Esposito

SCIENTIFIC REPORTS (2020)

Article Cell Biology

Characterization of HMGA1P6 transgenic mouse embryonic fibroblasts

Marco De Martino, Giuseppe Palma, Claudio Arra, Paolo Chieffi, Alfredo Fusco, Francesco Esposito

CELL CYCLE (2020)

Article Cell Biology

TheHMGA1-pseudogene7shows oncogenic activityin vivo

Marco De Martino, Francesco Esposito, Alfredo Fusco

CELL CYCLE (2020)

Review Biochemistry & Molecular Biology

miRNAs and Biomarkers in Testicular Germ Cell Tumors: An Update

Marco De Martino, Paolo Chieffi, Francesco Esposito

Summary: Testicular germ cell tumors are the leading form of solid cancer and death among males aged 20 to 40. The deregulation of miRNAs plays a key role in TGCTs, making them potential diagnostic and prognostic markers for testicular tumors.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cell Biology

MPPED2 is downregulated in glioblastoma, and its restoration inhibits proliferation and increases the sensitivity to temozolomide of glioblastoma cells

Simona Pellecchia, Marco De Martino, Francesco Esposito, Cristina Quintavalle, Alfredo Fusco, Pierlorenzo Pallante

Summary: GBM is classified into four subtypes based on molecular signature genes, with MPPED2 downregulation found in malignant neoplasias and being associated with poor prognosis. This study showed that restoring MPPED2 expression in GBM cell lines decreased cell growth, migration, and increased sensitivity to chemotherapy, suggesting a potential innovative therapy for GBM.

CELL CYCLE (2021)

Correction Multidisciplinary Sciences

HMGA1-pseudogene7 transgenic mice develop B cell lymphomas (vol 10, 7057, 2020)

Marco De Martino, Davide De Biase, Floriana Forzati, Sara Carmela Credendino, Giuseppe Palma, Antonio Barbieri, Claudio Arra, Orlando Paciello, Eugenio Gaudio, Maurilio Ponzoni, Gabriella De Vita, Paolo Chieffi, Francesco Bertoni, Alfredo Fusco, Francesco Esposito

SCIENTIFIC REPORTS (2021)

Review Oncology

Critical role of the high mobility group A proteins in hematological malignancies

Marco De Martino, Francesco Esposito, Alfredo Fusco

Summary: The HMGA protein family consists of three non-histone chromatin remodeling proteins that lack transcriptional activity but can modify chromatin modeling and regulate gene expression by interacting with AT-rich DNA sequences and the transcription machinery, playing a key role in human cancer and embryogenesis.

HEMATOLOGICAL ONCOLOGY (2022)

Article Cell Biology

The role of HMGA1 protein in gastroenteropancreatic neuroendocrine tumors

Marco De Martino, Simona Pellecchia, Francesco Esposito, Nadia Tosti, Cristina Quintavalle, Serenella Eppenberger-Castori, Vincenza Carafa, Alberto Righi, Paolo Chieffi, Alfredo Fusco, Luigi Maria Terracciano, Pierlorenzo Pallante

Summary: This study evaluated the expression of HMGA1 in neuroendocrine tumors and its role in tumor development. The results showed that HMGA1 is overexpressed in tumor samples and that its silencing interferes with the proliferation and migration abilities of tumor cells.

CELL CYCLE (2022)

Review Oncology

Noncoding RNAs in Thyroid-Follicular-Cell-Derived Carcinomas

Marco De Martino, Francesco Esposito, Maria Capone, Pierlorenzo Pallante, Alfredo Fusco

Summary: Thyroid tumors are the most common neoplastic pathology of the endocrine system, with mutations in oncogenes and tumor suppressor genes playing a role in their development. Noncoding RNAs have been found to be crucial in regulating gene expression and tumor progression in thyroid cancer. Evaluating the noncoding RNA network could lead to a more personalized approach in the diagnosis, prognosis, and treatment of thyroid cancer.

CANCERS (2022)

Review Oncology

Long non-coding RNAs regulating multiple proliferative pathways in cancer cell

Marco De Martino, Francesco Esposito, Pierlorenzo Pallante

Summary: Long non-coding RNAs (lncRNAs) are a diverse class of non-coding RNAs that modulate cellular pathways and are implicated in pathologies like cancer. They can act as oncogenes, tumor suppressors, or both in regulating cell proliferation. Interactions between lncRNAs and their molecular targets in controlling cell proliferation form a complex molecular network that may be helpful for treating molecular diseases like cancer in the future.

TRANSLATIONAL CANCER RESEARCH (2021)

No Data Available